A Six Sigma framework to successfully manage medication adherence.

adherence; drug utilization; health policy; Europe; Humans; Medication Therapy Management/organization & administration; Medication Therapy Management/standards; Organizations, Nonprofit/standards; Practice Guidelines as Topic; Societies, Scientific/standards; Total Quality Management/standards; Medication Adherence; Medication Therapy Management; Organizations, Nonprofit; Societies, Scientific; Total Quality Management; Pharmacology; Pharmacology (medical)

Disciplines :

Human health sciences: Multidisciplinary, general & others

Author, co-author :

Vrijens, Bernard ; Université de Liège - ULiège > Département des sciences de la santé publique ; Research and Development, AARDEX Group, Liège, Belgium

Language :

English

Title :

A Six Sigma framework to successfully manage medication adherence.

Publication date :

August 2019

Journal title :

British Journal of Clinical Pharmacology

ISSN :

0306-5251

eISSN :

1365-2125

Publisher :

Blackwell Publishing Ltd, England

Volume :

Issue :

Pages :

1661 - 1663

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbcp.13905

Funders :

Pfizer

Funding text :

This work was supported by Pfizer Inc. Medical writing support, under the guidance of the author, was provided by Christina Viegelmann, PhD, of CMC Connect, a division of McCann Health Medical Communications Ltd, Glasgow, UK, and was funded by Pfizer Inc, New York, NY, USA, in accordance with Good Publication Practice (GPP3) guidelines (Ann Intern Med 2015; 163: 461–464).

Available on ORBi :

since 18 July 2023

Statistics

Number of views

16 (2 by ULiège)

Number of downloads

17 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Hill-McManus D, Soto E, Marshall S, et al. Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout. Br J Clin Pharmacol. 2018;84:142-152.
Kronish IM, Moise N. In search of a “magic pill” for medication nonadherence. JAMA Intern Med. 2017;177(5):631-632.
De Geest S, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med. 2018;169(1):30-35.
Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691-705.
Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91.
Choudhry NK, Krumme AA, Ercole PM, et al. Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Intern Med. 2017;177(5):624-631.
Peters-Strickland T, Pestreich L, Hatch A, et al. Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole. Neuropsychiatr Dis Treat. 2016;12:2587-2594.
Parker BM, Henderson JM, Vitagliano S, et al. Six sigma methodology can be used to improve adherence for antibiotic prophylaxis in patients undergoing noncardiac surgery. Anesth Analg. 2007;104:140-146.
Cancelado Carretero HM, Pachón Serna AM. Enhancement for an adherence process on a diabetes program at an IPS, through Chronic Care Model (CCM), Clinical Decision Support Systems (CDSS) and Lean Six Sigma. In: International Conference on Industrial Engineering and Operations Management, Bogota, Colombia: IEOM Society International, 2017: 1315–1333.
National Institutes of Health. Improving patient adherence to treatment and prevention regimens to promote health (R01 Clinical Trial Optional). 2018. https://grants.nih.gov/grants/guide/pa-files/PA-18-722.html. Accessed 05/07/2018.
Demonceau J, Ruppar T, Kristanto P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73:545-562.
Avataneo V, De Nicolo A, Rabbia F, et al. Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. Br J Clin Pharmacol. 2018;84:2535-2543.
Gendelman O, Weitzman D, Rosenberg V, et al. Characterization of adherence and persistence profile in a real-life population of patients treated with adalimumab. Br J Clin Pharmacol. 2018;84:786-795.
Man WH, Perez-Pitarch A, Wilting I, et al. Development of a nomogram for the estimation of long-term adherence to clozapine therapy using neutrophil fluorescence. Br J Clin Pharmacol. 2018;84:1228-1237.